Tvardi Therapeutics, Inc 10-K for FY2021
Tvardi Therapeutics, Inc. (TVRD)
10-K
2022-03-01
For: 2021-12-31
View Original
Added on
April 09, 2026
About this 10-K
Tvardi Therapeutics, Inc filed this 10-K on March 1, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $23.03M
- down 83.0% from $135.08M a year earlier
- Net loss
- $88.44M
- compared with net income of $8.41M a year earlier
- Diluted EPS
- -$1.74
- compared with $0.18 a year earlier